Zelegent expands to OSA therapeutics with MISH platform acquisition
Category: #health  By Pankaj Singh  Date: 2019-09-16
  • share
  • Twitter
  • Facebook
  • LinkedIn

Zelegent expands to OSA therapeutics with MISH platform acquisition
  • MISH Technology stands for Minimally Invasive Suspension of the Hyoid and is a novel pre-clinical product line meant to treat obstructive sleep apnea (OSA).
  • MISH is relatively less invasive when compared with presently used hyoid suspension products since it does not require any external neck incision; a needle puncture site.

Zelegent, a U.S. based company involved in manufacturing of innovative equipment for otolaryngologist sleep specialists and whose Elevo® Set is currently being sold to physicians across the U.S., reportedly announced the acquisition of rights to a novel pre-clinical product line meant to treat obstructive sleep apnea (OSA).

The Elevo Snoring Intervention Set, existing product line of the company, is utilized by physicians for the treatment of primary snoring, particularly known as disruptive snoring among patients without OSA. The MISH technology platform is developed with the intention of providing an alternative to technologies currently in operation for treating OSA.

MISH stands for Minimally Invasive Suspension of the Hyoid. Hyoid bone suspension is an existing procedure for the OSA treatment which carries its unique reimbursement code. MISH is relatively less invasive when compared with presently operating hyoid suspension products, since it does not have any external neck incision; a needle puncture site.

Zelegent procured worldwide exclusive rights to MISH from Valam Corporation. Particular terms of the procurement have not been disclosed yet, except that the acquisition agreement includes both royalty and equity.

Chief Executive Officer at Zelegent, Alexander K. Arrow, MD stated that unlike currently running hyoid suspension devices, MISH process does not require a permanent implant. Arrow added that the components needed to suspend hyoid bone in the MISH procedure are entirely resorbable following implantation, further making the MISH process consistent with the theme of Elevo Set, Zelegent’s first product line.

Zelegent provides the Elevo Set product, via exclusive marketing, distribution and sales tie-up with Cook Medical.

Source credit: https://www.globenewswire.com/news-release/2019/09/15/1915627/0/en/Zelegent-Acquires-MISH-Technology-Platform-Extending-Product-Pipeline-into-Obstructive-Sleep-Apnea-Therapeutics.html



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

Yahoo Japan explores plans for a merger with Navers Line app
Yahoo Japan explores plans for a merger with Navers Line app
By Pankaj Singh

Yahoo! Japan Corp., a Japanese internet firm, has recently cleared the fog on its merger with trending messaging app Line. According to reports, the merger would see the formation of a new internet group that would cov...

Skyroam Solis X launched online for purchase or rental options
Skyroam Solis X launched online for purchase or rental options
By Pankaj Singh

In this era of smart technologies and digitalization, the need for high speed internet connectivity have been doing rounds globally. To suffice these requirements, Skyroam Hotspot has taken a step forward to equip its ...

Spell & The Gypsy Collective rolled out on Workarea Commerce Cloud
Spell & The Gypsy Collective rolled out on Workarea Commerce Cloud
By Pankaj Singh

Workarea Commerce, a renowned commerce platform for new merchants across various sectors, and Syatt Media, a Canada based e-commerce agency with deep platform and industry expertise, announced that Spell & The Gyps...